Science Explorer Back to mapMap
Discussion
Researcher · Genomics England · United Kingdom

Rob Jackson

Rob Jackson publishes mostly in Molecular Biology, Genetics and Cancer Research, on topics such as Genomics and Rare Diseases, Cancer Genomics and Diagnostics and Genetic and Kidney Cyst Diseases.

OpenAlex
World rank
#434,731
of 7,710,434 ranked researchers
Rank in United Kingdom
#38,254
of 367,258
Works
36
Citations
2.7k
Citations per work
74.0
h-index
22
i10-index 28Top 28% in Molecular Biology
Rob Jackson

What does Rob Jackson research?

Rob Jackson's work is mostly in Biochemistry, Genetics and Molecular Biology (59%), Medicine (5%), Immunology and Microbiology (4%).

Life Sciences: 24 works · 66.5% of their workBiochemistry, Genetics and Molecular Biology: 21 works · 58.7% of their workMolecular Biology: 10 works · 28.4% of their workGenetics: 8 works · 22.5% of their workCancer Research: 3 works · 7.8% of their workImmunology and Microbiology: 1 works · 3.9% of their workImmunology: 1 works · 3.9% of their workNeuroscience: 1 works · 3.9% of their workCellular and Molecular Neuroscience: 1 works · 3.9% of their workEverything else: 10 works · 28.6% of their workHealth Sciences: 2 works · 4.9% of their workMedicine: 2 works · 4.9% of their workPathology and Forensic Medicine: 2 works · 4.9% of their workTHEIR WORKRob Jackson36works
Life Sciences66%Health Sciences5%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2158.7%
    2. Immunology and Microbiology13.9%
    3. Neuroscience13.9%
  2. Everything else1028.6%
    1. Medicine24.9%
  1. 1Molecular Biology28% of their works
  2. 2Genetics22% of their works
  3. 3Cancer Research8% of their works
  4. 4Pathology and Forensic Medicine5% of their works
  5. 5Cellular and Molecular Neuroscience4% of their works
  6. 6Immunology4% of their works

Research topics

Which keywords describe Rob Jackson's research?

The keywords of their largest research topics: Genetic Variants, Sequence Interpretation, Cancer Genomics, Mutational Signatures, Alternative Splicing, Ciliopathies, Mitochondria and Primary Cilium.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Genetic Variants81 topic
  2. Sequence Interpretation81 topic
  3. Cancer Genomics71 topic
  4. Mutational Signatures71 topic
  5. Alternative Splicing41 topic
  6. Ciliopathies41 topic
  7. Mitochondria41 topic
  8. Primary Cilium41 topic
  9. RNA-Binding Proteins41 topic
  10. Reactive Oxygen Species41 topic
  11. Ehlers-Danlos Syndrome31 topic
  12. Marfan Syndrome31 topic
  13. RNA methylation31 topic
  14. Ribosome31 topic
  15. Translation31 topic
  16. m6A-seq31 topic

Where does Rob Jackson work?

Rob Jackson's main affiliation in the publication record is Genomics England, United Kingdom.

How many publications and citations does Rob Jackson have?

OpenAlex counts 36 works and 2,665 citations for Rob Jackson, an h-index of 22, ranking #434,731 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Rob Jackson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.